Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
מצבים רפואיים
Pancreatic Cancer · Pancreatic Cancer Metastatic · PDAC · PDAC - Pancreatic Ductal Adenocarcinoma · Pancreatic Ductal Adenocarcinoma · Pancreatic Adenocarcinoma Metastatic · Pancreatic Ductal Adenocarcinoma (PDAC) · Pancreatic Adenocarcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
City of Hope, Phoenix, Arizona, United States
City of Hope, Duarte, California, United States
Medical Oncology Hematology Consultants, Newark, Delaware, United States
Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida, United States
Piedmont Healthcare, Atlanta, Georgia, United States
Contact: Study coordinator (Eyal Meiri, MD)Illinois Cancer Specialists, Arlington Heights, Illinois, United States
City of Hope, Chicago, Illinois, United States
OSF Medical Center, Peoria, Illinois, United States
Maryland Oncology, Columbia, Maryland, United States
Missouri Cancer Associates, Columbia, Missouri, United States
Comprehensive Cancer Centers, Las Vegas, Nevada, United States
Regional Cancer Care, Belleville, New Jersey, United States
NYU Langone Health, New York, New York, United States
Taylor Cancer Research Center, Maumee, Ohio, United States
Willamette Valley Cancer Institute, Eugene, Oregon, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
Texas Oncology - West Texas, Abilene, Texas, United States
Texas Oncology - San Antonio, San Antonio, Texas, United States
Texas Oncology Gulf Coast, Webster, Texas, United States
Blue Ridge Cancer Care, Blacksburg, Virginia, United States
Virginia Cancer Specialists, Fairfax, Virginia, United States
Northwest Cancer Specialists, Vancouver, Washington, United States
Calvary Mater Newcastle, Waratah, New South Wales, Australia
Contact: Study coordinator (Prajwol Shrestha, MD)Icon Cancer Centre - Chermside, Chermside, Queensland, Australia
Contact: Study coordinator (Chun Gan, MD)